Edition:
United States

People: United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

125.61USD
17 Aug 2018
Change (% chg)

$-3.85 (-2.97%)
Prev Close
$129.46
Open
$129.91
Day's High
$129.91
Day's Low
$124.69
Volume
140,790
Avg. Vol
147,406
52-wk High
$152.55
52-wk Low
$100.64

Mahon, Paul 

Mr. Paul A. Mahon, J.D. serves as Executive Vice President, General Counsel, Corporate Secretary of the Company. He has served as General Counsel and Corporate Secretary of United Therapeutics since its inception in 1996. In June 2001, Mr. Mahon joined United Therapeutics full-time as Senior Vice President, General Counsel and Corporate Secretary. In November 2003, Mr. Mahon was promoted to Executive Vice President, General Counsel and Corporate Secretary. Prior to June 2001, he served United Therapeutics, beginning with its formation in 1996, in his capacity as principal and managing partner of a law firm specializing in technology and media law.

Basic Compensation

Total Annual Compensation, USD 815,950
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 11,399,200
Fiscal Year Total, USD 12,215,200

Options Compensation

  Quantity Market Value
Exercisable 108,030 4,771,620.00
Unexercisable 246,732 5,152,440.00
Exercised 122,750 9,543,330.00
Name Fiscal Year Total

Martine Rothblatt

35,535,000

Michael Benkowitz

10,818,700

Christopher Patusky

570,953

James Edgemond

8,075,900

Paul Mahon

12,215,200

Raymond Dwek

488,652
As Of  30 Dec 2017